CHS INC CUM RED PRF 'B' USD25
CHSCO
25.70
+0.05
+0.19%
CHS INC CUM RED PRF 'B' USD25
US · CHSCO
#2785 by market cap
Listed 1970
25.70
+0.05
+0.19%
Live - 5344 symbols - heartbeat 98s ago
· 2026-10-08 07:38
Pre-market
25.70
0.00%
After-hours
25.70
0.00%
- Market cap
- 2.00B
- P/E (TTM)i
- 0.00
- P/Bi
- 0.33
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 82%
Reader sentiment
Are you bullish or bearish on CHSCO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.42, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.02% YoY
Margins
- Gross margin
- 3.35%
- Operating margin
- 1.40%
- Net margin
- 2.37%
Key ratios & quality
- Enterprise valuei
- 5.76B
- Altman Z-Scorei
- 2.42
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.92B | 40.60B | 44.48B | 42.66B | 34.58B | 30.36B | 32.04B | 32.68B |
| Gross profit | 1.40B | 2.01B | 1.78B | 1.65B | 1.49B | 968.75M | 894.66M | 1.09B |
| Selling & admin expenses | 438.50M | 498.23M | 553.62M | 602.60M | 642.31M | 601.27M | 612.01M | 674.08M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 964.35M | 1.51B | 1.23B | 1.05B | 715.41M | 292.44M | -174.03M | 457.09M |
| Pretax profit | 1.15B | 1.42B | 1.09B | 1.13B | 768.17M | 402.13M | -110.17M | 671.23M |
| Tax | 86.63M | 80.85M | 89.67M | 48.30M | -12.17M | 19.10M | -181.12M | -104.08M |
| Net profit | 1.06B | 1.34B | 996.33M | 1.08B | 780.33M | 383.03M | 70.96M | 775.31M |
| Basic EPS | -- | -- | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2017-11 | 2018-02 | 2018-05 | 2018-08 | 2018-11 | 2019-02 |
|---|---|---|---|---|---|---|
| Revenue | 8.03B | 6.98B | 9.03B | 8.76B | 8.48B | 6.48B |
| Gross profit | 320.49M | 134.97M | 298.61M | 339.10M | 470.64M | 427.41M |
| Selling & admin expenses | 140.35M | 187.56M | 161.58M | 185.62M | 162.50M | 177.43M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 183.93M | -41.24M | 140.84M | 172.24M | 314.50M | 249.65M |
| Pretax profit | 207.79M | -21.73M | 289.48M | 196.74M | 367.23M | 261.86M |
| Tax | 20.61M | -187.69M | 60.34M | -3.18M | 20.12M | 13.55M |
| Net profit | 187.18M | 165.96M | 229.15M | 199.92M | 347.12M | 248.30M |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.74B | 9.67B | 8.91B | 9.40B | 8.01B | 6.94B | 5.63B | 6.69B |
| Cash & ST investments | 937.69M | 314.03M | 1.81B | 2.13B | 953.81M | 279.31M | 181.38M | 450.62M |
| Inventory | 2.77B | 3.20B | 2.66B | 2.76B | 2.65B | 2.37B | 2.60B | 2.77B |
| Total assets | 12.22B | 13.65B | 13.50B | 15.30B | 15.23B | 17.31B | 15.82B | 16.38B |
| Total current liabilities | 5.96B | 6.82B | 5.79B | 6.23B | 5.26B | 6.52B | 5.48B | 5.93B |
| Short-term debt | 1.00B | 911.83M | 1.05B | 1.36B | 1.34B | 2.95B | 2.14B | 2.44B |
| Long-term debt | 1.41B | 1.33B | 1.45B | 1.40B | 1.26B | 2.08B | 2.02B | 1.76B |
| Total liabilities | 7,951,690,000.00 | 9,171,701,000.00 | 8,351,523,000.00 | 8,829,260,000.00 | 7,558,901,000.00 | 9,445,885,000.00 | 8,113,282,000.00 | 8,216,150,000.00 |
| Total equity | 4.27B | 4.47B | 5.15B | 6.47B | 7.67B | 7.87B | 7.71B | 8.17B |
| Retained earnings | 1.08B | 1.26B | 1.38B | 1.60B | 1.60B | 1.58B | 1.27B | 1.48B |
| Line item | 2017-11 | 2018-02 | 2018-05 | 2018-08 | 2018-11 | 2019-02 |
|---|---|---|---|---|---|---|
| Total current assets | 6.68B | 7.19B | 7.03B | 6.69B | 7.19B | 7.39B |
| Cash & ST investments | 252.13M | 190.43M | 533.89M | 450.62M | 266.15M | 367.31M |
| Inventory | 3.05B | 3.65B | 2.94B | 2.77B | 3.18B | 3.55B |
| Total assets | 16.78B | 17.08B | 16.94B | 16.38B | 16.85B | 16.94B |
| Total current liabilities | 6.24B | 6.67B | 6.38B | 5.93B | 6.25B | 6.26B |
| Short-term debt | 2.55B | 3.04B | 2.87B | 2.44B | 2.57B | 2.81B |
| Long-term debt | 1.94B | 1.92B | 1.91B | 1.76B | 1.74B | 1.74B |
| Total liabilities | 8,846,648,000.00 | 9,022,902,000.00 | 8,773,246,000.00 | 8,216,150,000.00 | 8,561,664,000.00 | 8,533,945,000.00 |
| Total equity | 7.94B | 8.06B | 8.16B | 8.17B | 8.29B | 8.40B |
| Retained earnings | 1.52B | 1.65B | 1.80B | 1.48B | 1.66B | 1.79B |
Cash flow
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 301.32M | 718.64M | 2.47B | 1.44B | 570.01M | 1.26B | 919.12M | 1.07B |
| Depreciation & amortization | 220.69M | 219.63M | 276.58M | 306.25M | 355.42M | 447.49M | 480.22M | 478.05M |
| Free cash flow | -9.35M | 250.03M | 1.85B | 522.17M | -616.78M | 567.77M | 474.72M | 716.66M |
| Dividends paid | -24.54M | -24.54M | -24.54M | -50.76M | -133.71M | -163.32M | -167.64M | -168.67M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 937.69M | 314.03M | 1.81B | 2.13B | 953.81M | 290.27M | 181.38M | 450.62M |
| Line item | 2017-11 | 2018-02 | 2018-05 | 2018-08 | 2018-11 | 2019-02 |
|---|---|---|---|---|---|---|
| Operating cash flow | -153.54M | -488.86M | 494.87M | 1.22B | -94.80M | -30.45M |
| Depreciation & amortization | 120.15M | 120.20M | 117.79M | 119.92M | 118.60M | 115.03M |
| Free cash flow | -239.36M | -545.92M | 388.68M | 1.11B | -199.55M | -103.69M |
| Dividends paid | -42.17M | -42.17M | -42.17M | -42.17M | -42.17M | -42.17M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 343.41M | 291.17M | 533.89M | 450.62M | 341.89M | 457.36M |
Returns & efficiency
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 29.08 | 32.61 | 22.18 | 21.48 | 14.53 | 7.64 | 2.28 | 13.47 |
| ROA %i | 9.21 | 9.83 | 7.37 | 7.55 | 5.14 | 2.61 | 0.77 | 4.80 |
| ROIC %i | 19.80 | 22.91 | 17.34 | 15.95 | 10.24 | 5.01 | 2.26 | 8.90 |
| 5-year avg ROE %i | 24.56 | 24.35 | 22.87 | 24.52 | 23.98 | 19.54 | 13.28 | 11.58 |
| EBIT margin %i | 3.33 | 3.97 | 2.98 | 2.98 | 2.43 | 1.76 | 0.36 | 2.51 |
| FCF / sales %i | -- | 0.56 | 4.09 | 1.13 | -- | 1.88 | 1.53 | 2.19 |
| Current ratioi | 1.47 | 1.42 | 1.54 | 1.51 | 1.52 | 1.06 | 1.03 | 1.13 |
| Quick ratioi | 0.66 | 0.57 | 0.82 | 0.82 | 0.72 | 0.48 | 0.38 | 0.49 |
| Debt / assetsi | 19.77 | 16.45 | 18.49 | 18.08 | 17.05 | 29.05 | 26.33 | 25.65 |
| LT debt / equityi | 39.24 | 32.21 | 30.14 | 26.69 | 22.96 | 37.14 | 37.27 | 29.92 |
| Interest coveragei | 14.83 | 8.33 | 5.57 | 8.97 | 11.87 | 4.69 | 0.68 | 5.50 |
| Revenue CAGR (3Y) %i | 4.70 | 16.42 | 20.74 | 4.94 | -5.21 | -11.96 | -9.11 | -1.87 |
| Net income CAGR (3Y) %i | 6.18 | 48.96 | 25.49 | 4.00 | -14.75 | -27.18 | -59.55 | -0.22 |
| FCF CAGR (3Y) %i | -- | -43.89 | -- | -- | -- | -32.58 | -3.13 | -- |
| Line item | 2017-11 | 2018-02 | 2018-05 | 2018-08 | 2018-11 | 2019-02 |
|---|---|---|---|---|---|---|
| ROE %i | 1.74 | 4.37 | 9.16 | 13.47 | 16.02 | 17.10 |
| ROA %i | 0.56 | 1.41 | 3.08 | 4.80 | 5.56 | 5.99 |
| ROIC %i | 1.91 | 3.35 | 6.05 | 8.90 | 10.19 | 10.77 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.29 | 0.17 | 1.77 | 2.51 | 2.95 | 3.87 |
| FCF / sales %i | 0.44 | 1.72 | 0.58 | 2.19 | 2.28 | 3.67 |
| Current ratioi | 1.07 | 1.08 | 1.10 | 1.13 | 1.15 | 1.18 |
| Quick ratioi | 0.37 | 0.29 | 0.43 | 0.49 | 0.47 | 0.41 |
| Debt / assetsi | 26.74 | 29.01 | 28.21 | 25.65 | 25.57 | 26.90 |
| LT debt / equityi | 34.21 | 33.11 | 32.37 | 29.92 | 28.91 | 28.46 |
| Interest coveragei | 0.53 | 0.32 | 3.06 | 5.50 | 6.64 | 8.50 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Ag is the largest reported line at 76.65% of revenue, across 4 reported segments.
- The next-largest line, Energy, is a distant second at 24.69% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Ag76.65%
Energy24.69%
Corporate and Other0.20%
Region
United States90.19%
South America4.80%
Asia Pacific (APAC)3.37%
Europe, the Middle East and Africa (EMEA)1.64%
Quote time 2026-10-08 07:38:34 · For reference only, not investment advice and not tailored to your situation.